Why Is AT&T Stock Dropping?
The telecommunications giant AT&T Inc. (NYSE:T) has perhaps surprisingly eclipsed…
Sell
48
SVA Quote, Financials, Valuation and Earnings
Last price:
$6.47
Seasonality move
:
5.21%
Day range:
$6.47 - $6.47
52-week range:
$6.25 - $6.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.50x
P/B ratio:
0.05x
Volume:
--
Avg. volume:
--
1-year change:
--
Market cap:
$464.9M
Revenue:
$448.3M
EPS (TTM):
-$1.31
Earnings Data
Next earnings date for SVA
Aug 15
2025
Most recent earnings per share
$0.96
Beat by $0.96
(Dec 31/2020)
Consensus Estimate
--
(Dec 31/2020)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SVA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2020 | Q4 | -- | -- | $0.96 | -- | -- |
| 12/07/2020 | Q3 | -- | -- | $0.10 | -- | -- |
| 08/28/2020 | Q2 | -- | -- | -$0.05 | -- | -- |
| 04/30/2020 | Q1 | -- | -- | -$0.07 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | $0.20 | -- | -- |
| 11/15/2019 | Q3 | -- | -- | $0.06 | -- | -- |
| 07/10/2019 | Q2 | -- | -- | $0.11 | -- | -- |
| 04/29/2019 | Q1 | -- | -- | $0.01 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$0.03 | -- | -- |
| 11/08/2018 | Q3 | -- | -- | $0.12 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | $0.10 | -- | -- |
| 05/11/2018 | Q1 | -- | -- | $0.14 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | $0.09 | -- | -- |
| 11/28/2016 | Q3 | -- | -- | $0.06 | -- | -- |
| 08/23/2016 | Q2 | -- | -- | -$0.17 | -- | -- |
| 04/05/2016 | Q1 | -- | -- | $0.02 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -- | -- | -- |
| 11/12/2015 | Q3 | -- | -- | -$0.03 | -$0.02 | -$0.01 |
| 08/12/2015 | Q2 | -- | -- | $0.04 | -$0.01 | $0.05 |
| 04/20/2015 | Q1 | -- | -- | -$0.04 | $0.02 | -$0.06 |
Sinovac Biotech Earnings Questions
-
How Much did Sinovac Biotech Generate in Revenue Last Quarter?
Sinovac Biotech reported -- worth of top line sales in its most recent quarter.
-
Did Sinovac Biotech Beat Earnings Last Quarter?
Sinovac Biotech announced earnings per share of $0.96 which represents a beat of analyst forecast a -- per share.
-
Is Sinovac Biotech Profitable?
Sinovac Biotech reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Sinovac Biotech EPS Next Year?
Sinovac Biotech's earnings are forecast to grow from -$1.06 per share to -- per share next year representing an increase of --.
-
When is Sinovac Biotech's Earnings Date?
Sinovac Biotech's next earnings date is August 15, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is American Express Stock Going Lower?
American Express Company (NYSE:AXP) has long been a Buffett favorite…
Cigna vs Costco Stock: Which Is Best?
Cigna and Costco don’t usually go hand in hand but…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 38x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
45
QMCO alert for Jan 18
Quantum [QMCO] is down 15.61% over the past day.
Buy
51
QRVO alert for Jan 18
Qorvo [QRVO] is up 14.47% over the past day.
Sell
31
ATEX alert for Jan 18
Anterix [ATEX] is up 11.14% over the past day.
